Young onset type 2 diabetes patients have an increased risk of developing diabetic retinopathy at an earlier stage and at a greater frequency, according to researchers in India and US.
Diabetic retinopathy (DR) is one of the late complications of diabetes and usually it affects people who have had diabetes for considerably longer duration. Research [1] from the Madras Diabetes Research Foundation (MDRF), India has now demonstrated that young onset type 2 diabetes patients possess an increased risk of developing diabetic retinopathy at an earlier stage and at a greater frequency accompanied by the elevated levels of certain biomarkers such as monocyte chemotactic protein 1 (MCP-1) and cathepsin-D.
